Among the total number of deaths caused by different types of cancer, esophageal cancer is the sixth most significant. Several conventional treatments, such as radiotherapy, chemotherapy, and surgery have multiple side effects, including off-target toxicity and multidrug resistance (MDR).
Another strategy for esophageal cancer treatment is chemo-photodynamic therapy, the efficacy of which is limited by its inability to target tumors, lack of suitable microenvironment for photodynamic therapy (PDT), and tendency to cause adverse side effects.
Scientists sought to address these limitations of the existing therapies and developed a novel theranostic nanoplatform, namely, GCDs-Ce6/Pt-EGF, which has been found to be effective against esophageal cancer. This study has been recently published in Biomedicine & Pharmacotherapy.
Conventional Treatments of Esophageal Cancer
The majority of the available treatments for esophageal cancers come with some limitations. For instance, as this type of cancer is prone to metastasis, surgery cannot completely remove the tumor. In the case of radiotherapy, the narrow dose window limits its purpose. Low-dose radionuclides have limited tumor cell killing ability, while high dosage can affect healthy cells as well.
Although chemotherapy, using Cisplatin or Doxorubicin, can effectively eliminate tumor cells with metastasis and has a superior anti-tumor effect, it often severely damages the kidney and liver of the patient. Combinational therapy, such as chemoradiation with surgery, was effective against esophageal cancer, but this therapy showed high in-hospital mortality.
Two of the limitations associated with photothermal therapy and oxidative therapy are the recurrence of tumor cells and damage caused to off-target non-cancerous cells as well. PDT is effective against different types of cancers, such as breast, prostate, liver, and esophagus, with a better biosafety effect. However, its effectiveness is compromised by abundant glutathione (GSH) in the tumor microenvironment and hypoxia.
Nanotechnology-based Cancer Treatments
Nanoparticles are widely used in biomedical research, owing to their nanoscale dimension (1–100 nm) and multiple unique properties. Carbon nanodots are a type of carbon nanoparticle that is applied for fluorescence sensing, bioimaging, and drug delivery. The development of tumor-targeted drug delivery systems is essential to facilitate tumor-specific treatment without adversely affecting the normal cells.
Drugs are often modified to identify tumor cells by recognizing specific receptors expressed in them. In many types of cancers, including esophageal cancer, the epidermal growth factor receptor (EGFR) is found to be overexpressed. Compared to healthy individuals, esophageal cancer patients exhibit a significantly higher expression of EGFR protein in the mucosa. Hence, this receptor has been utilized as a key target for anti-tumor drug delivery.
A Novel Theranostic Nanoplatform for Esophageal Cancer Treatment
Recently, scientists have developed an all-in-one theranostic nanoplatform, known as GCDs-Ce6/Pt-EGF for esophageal cancer treatment. This nanoplatform utilized green fluorescence carbon dots (GCDs), which were synthesized using p-aminosalicylic acid and p-aminobenzamide with a molar ratio of 1:1 at 200℃ for 6 hours, via the hydrothermal method.
GCDs were characterized using atomic force microscopy (AFM) and transmission electron microscopy (TEM), which revealed a uniform dispersion of quasi-sphere GCD nanomaterials of 4.72 nm size. The fluorescence quantum yield of GCDs was estimated to be 10.62%. Most importantly, this nanoparticle exhibited excellent optical stability.
To construct the GCDs-Ce6/Pt-EGF nanoplatform, researchers grafted chlorin e6 (Ce6), which is a photosensitizer, chemotherapy agent Pt (IV), and the targeting unit epidermal growth factor (EGF) on GCDs. Here, the drug loading rates of Ce6 and Pt (IV) were estimated to be 8.53% and 19.36%, respectively. The drug loading capacity of GCDs-Ce6/Pt-EGF nanoplatform was observed to be significantly more than other nanoplatforms.
Post irradiation at 660 nm wavelength, photosensitizer Ce6 induced cell death by generating reactive oxygen species (ROS). This phenomenon induced tumor cell apoptosis. Both in vitro and in vivo studies strongly indicated that the GCDs-Ce6/Pt-EGF exhibited superior photodynamic properties and could be effectively applied for esophageal tumor imaging as well as the elimination of esophageal cancer cells (therapeutic effect).
The mechanism driving the GCDs-Ce6/Pt-EGF nanoplatform is the targeting of esophageal cancer cells, bearing EGFR, and penetration of the tumor cells. After internalization within the tumor cells, Pt(IV) gets converted to Pt(II) by intracellular GSH, which ultimately kills tumor cells.
Interestingly, this study revealed that GCDs-Ce6/Pt-EGF displayed better anti-tumor effects compared to Cisplatin. Researchers stated that this nanomedicine could not only restrict tumor cell migration but also target tumor cells by recognizing EGF receptors. Other important aspects of this theranostic nanoplatform are direct cell killing capacity by Pt(II) and laser irradiation.
The GCDs-Ce6/Pt-EGF nanoplatform displayed excellent biosafety, as it rendered negligible cytotoxicity to normal esophageal cells. This could be due to three reasons, i.e., superior tumor targeting capability that reduces off-target toxicity, the release of toxic platinum only in GSH-rich tumor microenvironment, and Ce6 induced PDT effect with laser irradiation. Scientists are optimistic that utilizing all-in-one GCDs-Ce6/Pt-EGF theranostic nanoplatform could be beneficial for treating esophageal cancer patients.
News
New nanomedicine wipes out leukemia in animal study
In a promising advance for cancer treatment, Northwestern University scientists have re-engineered the molecular structure of a common chemotherapy drug, making it dramatically more soluble and effective and less toxic. In the new study, [...]
Mystery Solved: Scientists Find Cause for Unexplained, Deadly Diseases
A study reveals that a protein called RPA is essential for maintaining chromosome stability by stimulating telomerase. New findings from the University of Wisconsin-Madison suggest that problems with a key protein that helps preserve chromosome stability [...]
Nanotech Blocks Infection and Speed Up Chronic Wound Recovery
A new nanotech-based formulation using quercetin and omega-3 fatty acids shows promise in halting bacterial biofilms and boosting skin cell repair. Scientists have developed a nanotechnology-based treatment to fight bacterial biofilms in wound infections. The [...]
Researchers propose five key questions for effective adoption of AI in clinical practice
While Artificial Intelligence (AI) can be a powerful tool that physicians can use to help diagnose their patients and has great potential to improve accuracy, efficiency and patient safety, it has its drawbacks. It [...]
Advancements and clinical translation of intelligent nanodrugs for breast cancer treatment
A comprehensive review in "Biofunct. Mater." meticulously details the most recent advancements and clinical translation of intelligent nanodrugs for breast cancer treatment. This paper presents an exhaustive overview of subtype-specific nanostrategies, the clinical benefits [...]
It’s Not “All in Your Head”: Scientists Develop Revolutionary Blood Test for Chronic Fatigue Syndrome
A 96% accurate blood test for ME/CFS could transform diagnosis and pave the way for future long COVID detection. Researchers from the University of East Anglia and Oxford Biodynamics have created a highly accurate [...]
How Far Can the Body Go? Scientists Find the Ultimate Limit of Human Endurance
Even the most elite endurance athletes can’t outrun biology. A new study finds that humans hit a metabolic ceiling at about 2.5 times their resting energy burn. When ultra-runners take on races that last [...]
World’s Rivers “Overdosing” on Human Antibiotics, Study Finds
Researchers estimate that approximately 8,500 tons of antibiotics enter river systems each year after passing through the human body and wastewater treatment processes. Rivers spanning millions of kilometers across the globe are contaminated with [...]
Yale Scientists Solve a Century-Old Brain Wave Mystery
Yale scientists traced gamma brain waves to thalamus-cortex interactions. The discovery could reveal how brain rhythms shape perception and disease. For more than a century, scientists have observed rhythmic waves of synchronized neuronal activity [...]
Can introducing peanuts early prevent allergies? Real-world data confirms it helps
New evidence from a large U.S. primary care network shows that early peanut introduction, endorsed in 2015 and 2017 guidelines, was followed by a marked decline in clinician-diagnosed peanut and overall food allergies among [...]
Nanoparticle blueprints reveal path to smarter medicines
Lipid nanoparticles (LNPs) are the delivery vehicles of modern medicine, carrying cancer drugs, gene therapies and vaccines into cells. Until recently, many scientists assumed that all LNPs followed more or less the same blueprint, [...]
How nanomedicine and AI are teaming up to tackle neurodegenerative diseases
When I first realized the scale of the challenge posed by neurodegenerative diseases, such as Alzheimer's, Parkinson's disease and amyotrophic lateral sclerosis (ALS), I felt simultaneously humbled and motivated. These disorders are not caused [...]
Self-Organizing Light Could Transform Computing and Communications
USC engineers have demonstrated a new kind of optical device that lets light organize its own route using the principles of thermodynamics. Instead of relying on switches or digital control, the light finds its own [...]
Groundbreaking New Way of Measuring Blood Pressure Could Save Thousands of Lives
A new method that improves the accuracy of interpreting blood pressure measurements taken at the ankle could be vital for individuals who are unable to have their blood pressure measured on the arm. A newly developed [...]
Scientist tackles key roadblock for AI in drug discovery
The drug development pipeline is a costly and lengthy process. Identifying high-quality "hit" compounds—those with high potency, selectivity, and favorable metabolic properties—at the earliest stages is important for reducing cost and accelerating the path [...]
Nanoplastics with environmental coatings can sneak past the skin’s defenses
Plastic is ubiquitous in the modern world, and it's notorious for taking a long time to completely break down in the environment - if it ever does. But even without breaking down completely, plastic [...]
